Cargando…
Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study
INTRODUCTION: We investigated the safety and explore potential efficacy of batoclimab administered subcutaneously in Chinese patients with generalized myasthenia gravis (gMG). METHODS: A randomized, double-blinded, placebo-controlled, parallel phase II study was conducted. First, in the double-blind...
Autores principales: | Yan, Chong, Duan, Rui-Sheng, Yang, Huan, Li, Hai-Feng, Zou, Zhangyu, Zhang, Hua, Zhou, Hongyu, Li, Xiao-Li, Zhou, Hao, Jiao, Lidong, Chen, Jialin, Yin, Jian, Du, Qin, Lee, Michael, Chen, Yu, Chen, Xiaoxiang, Zhao, Chongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095773/ https://www.ncbi.nlm.nih.gov/pubmed/35412216 http://dx.doi.org/10.1007/s40120-022-00345-9 |
Ejemplares similares
-
Pneumonia in myasthenia gravis: Microbial etiology and clinical management
por: Su, Manqiqige, et al.
Publicado: (2022) -
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
por: Zhou, Lei, et al.
Publicado: (2017) -
Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022) -
Clinical Features of Myasthenia Gravis With Antibodies to MuSK Based on Age at Onset: A Multicenter Retrospective Study in China
por: Zhou, Yufan, et al.
Publicado: (2022) -
Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
por: Duan, Weiwei, et al.
Publicado: (2022)